Efficacy and Safety of an Everolimus/Enteric-Coated Mycophenolate Sodium Regimen after Calcineurin Inhibitor Withdrawal in De Novo Renal Transplant Patients: Results of the ZEUS Trial

被引：0
|
作者：
Pietruck, F.
Becker, T.
Arns, W.
Sommerer, C.
Reinke, P.
Eisenberger, U.
Fischer, W. [1 ]
Kramer, S. [1 ]
Budde, K.
机构：
[1] Novartis Pharmaceut, Nurnberg, Germany
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2009年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：499 / 499
页数：1
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF AN EVEROLIMUS/ENTERICCOATED MYCOPHENOLATE SODIUM REGIMEN AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN DE NOVO RENAL TRANSPLANT PATIENTS: RESULTS OF THE ZEUS TRIAL
    Reinke, P.
    Arns, W.
    Becker, T.
    Eisenberger, U.
    Fischer, W.
    Kramer, S.
    Pietruck, F.
    Sommerer, C.
    Budde, K.
    [J]. TRANSPLANT INTERNATIONAL, 2009, 22 : 53 - 53
  • [2] RENAL FUNCTION IN EVEROLIMUS/ENTERIC-COATED MYCOPHENOLATE SODIUM TREATED DE NOVO RENAL TRANSPLANT RECIPIENTS AFTER CALCINEURIN INHIBITOR WITHDRAWAL: THE ZEUS STUDY
    Becker, T.
    Arns, W.
    Budde, K.
    Eisenberger, U.
    Fischer, W.
    Kramer, S.
    Reinke, P.
    Sommerer, C.
    Pietruck, F.
    [J]. TRANSPLANT INTERNATIONAL, 2009, 22 : 78 - 79
  • [3] Improved Renal Function of an Everolimus/Enteric-Coated Mycophenolate Sodium Regimen after Calcineurin Inhibitor Withdrawal in De Novo Renal Transplant Patients: 2 Years Follow-Up of the ZEUS Trial
    Budde, K.
    Arns, W.
    Sommerer, C.
    Reinke, P.
    Eisenberger, U.
    Fischer, W.
    Kramer, S.
    Pietruck, F.
    Becker, T.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 503 - 503
  • [4] Improved Renal Function of an Everolimus/Enteric-Coated Mycophenolate Sodium Regimen after Calcineurin Inhibitor Withdrawal in de Novo Renal Transplant Patients: 4 Years Follow-Up of the ZEUS Trial
    Witzke, O.
    Lehner, F.
    Arns, W.
    Reinke, P.
    Eisenberger, U.
    Paulus, E. -M
    May, C.
    Budde, K.
    Sommerer, C.
    [J]. TRANSPLANTATION, 2012, 94 (10) : 993 - 993
  • [5] IMPROVED RENAL FUNCTION OF AN EVEROLIMUS/ENTERIC-COATED MYCOPHENOLATE SODIUM REGIMEN AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN DE NOVO RENAL TRANSPLANT PATIENTS: 3 YEAR FOLLOW-UP OF THE ZEUS TRIAL
    Lehner, Frank
    Budde, Klemens
    Arns, Wolfgang
    Sommerer, Claudia
    Reinke, Petra
    Eisenberger, Ute
    Vogel, Eva-Maria
    Scheidl, Stefan
    Witzke, Oliver
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 57 - 57
  • [6] Improved Renal Function of an Everolimus/Enteric-Coated Mycophenolate Sodium Regimen after Calcineurin Inhibitor Withdrawal in De Novo Renal Transplant Patients: 5 Years Follow-Up of the ZEUS Trial
    Budde, K.
    Witzke, O.
    Sommerer, C.
    Reinke, P.
    Eisenberger, U.
    Paulus, E.
    Porstner, M.
    May, C.
    Arns, W.
    Lehner, F.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 35 - 36
  • [7] Improved Renal Function of an Everolimus/Enteric-Coated Mycophenolate Sodium Regimen after Calcineurin Inhibitor Withdrawal in De Novo Renal Transplant Patients: 3 Years Follow-Up of the ZEUS Trial
    Budde, K.
    Arns, W.
    Sommerer, C.
    Reinke, P.
    Eisenberger, U.
    Vogel, E. -M.
    Kramer, S.
    Witzke, O.
    Becker, T.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 66 - 66
  • [8] THREE YEARS FOLLOW-UP OF THE ZEUS TRIAL: MAINTAINED BETTER RENAL FUNCTION OF AN EVEROLIMUS/ENTERIC-COATED MYCOPHENOLATE SODIUM REGIMEN AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN DE NOVO RENAL TRANSPLANT PATIENTS
    Lehner, F.
    Arns, W.
    Witzke, O.
    Budde, K.
    Sommerer, C.
    Eisenberger, U.
    Paulus, E. -M.
    Scheidl, S.
    Reinke, P.
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 50 - 50
  • [9] Improved Renal Function of an Everolimus/Enteric-Coated Mycophenolate Sodium Regimen after Calcineurin Inhibitor Withdrawal in De Novo Renal Transplant Patients: 4 Years Follow-Up of the ZEUS Trial.
    Budde, K.
    Lehner, F.
    Arns, W.
    Reinke, P.
    Eisenberger, U.
    Paulus, E. -M.
    May, C.
    Sommerer, C.
    Witzke, O.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 298 - 298
  • [10] CONVERSION TO AN EVEROLIMUS/ENTERIC-COATED MYCOPHENOLATE SODIUM REGIMEN AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN DE NOVO RENAL TRANSPLANT PATIENTS IMPROVES RENAL FUNCTION: 2 YEARS FOLLOW-UP OF THE ZEUS TRIAL
    Sommerer, C.
    Becker, T.
    Budde, K.
    Pietruck, F.
    Eisenberger, U.
    Fischer, W.
    Kramer, S.
    Reinke, P.
    Arns, W.
    [J]. TRANSPLANT INTERNATIONAL, 2010, 23 : 60 - 60
12345